PATENT CLAIM ANALYSIS

Application Number: 15562825
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["544", "183000"]

Abstract:
The present invention relates to a tyrosine kinase inhibitor and a pharmaceutical composition comprising same. The tyrosine kinase inhibitor of the present invention has the structures as shown in the following formula (I) or (II):

Claim (Index 26):
A compound or an enantiomer, a diastereomer, a geometric isomer, a solvate or a pharmaceutically acceptable salt thereof according to  claim 18 , wherein R 2d1 , R 2d2  and R 2d3  are each independently selected from H, OH, methyl, or the structural unit \u2014N(R 2d1 R 2d2 \u2014) is selected from the group consisting of

Metadata:
- Claim Count in Document: 56.0
- Percentile: 94.0
- Lexical Diversity: 1.36667
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15812142', '15750704', '16470111', '15314599', '16326976']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8373443712837202
- 35 USC 102 Novelty (BERT): 0.5315831753355004
- Combined Prediction Score: 0.8067682516888982
- Mean Citation Score: 357.22619
- Max Citation Score: 380.52487
- Similarity Product: 300.8747844242394

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test